The Genesis of GT Medical Technologies and GammaTile® Therapy
For decades, clinicians have sought better treatment options for patients with brain tumors that would effectively target tumor cells while preserving eloquent tissue.
Driven to overcome the limitations of current treatments and raise the standard of care, a group of brain tumor specialists joined forces to address this critical, unmet need. Together with medical device experts, they developed GammaTile Therapy, Surgically Targeted Radiation Therapy (STaRT) for recurrent intracranial neoplasms.
GT Medical Technologies is dedicated to improving the lives of patients with brain tumors.
Our Operating Principles
We are focused on improving the lives of patients with brain tumors by supporting our customers in all that we do.
We are a team that is committed to the success of our company. We value all opinions; respectfully speak our minds; listen intently; agree to disagree, and commit to our decisions.
We cooperate within the organization and with our partners in pursuit of improving the lives of patients with brain tumors.
We are a team that behaves consistently to produce predictable positive outcomes and encourage trust.
We abide by industry and regulatory guidelines in operating our business.
We produce innovative solutions that advance our purpose of improving the lives of patients with brain tumors.
We optimize value for all stakeholders, beginning with the patient and through external relationships, which ultimately results in greater enterprise value.
We achieve objectives with sustained effort despite difficulties, setbacks, or opposition—doggedly pursuing our purpose.